文献速递重症综合管理与镇静镇痛

衰弱与危重患者短期结局、器官支持及资源使用的关系

Association of frailty with short-term outcomes, organ support and resource use in critically ill patients.
PubMed 文献 · Intensive Care Med · 2018-08-13
一句话结论在巴西93个ICU的129,680例患者中,MFI评估的衰弱与院内死亡OR 2.42及更多器官支持使用相关。

该研究回顾性分析2014至2015年巴西93个ICU前瞻性收集的数据,纳入129,680例患者,用改良衰弱指数(MFI)评估衰弱。主要结局为院内死亡,次要结局包括出院回家无需护理、ICU及住院时长、器官支持与输血使用。校正混杂后,衰弱与院内死亡升高相关(OR 2.42,95%CI 1.89-3.08),在SOFA评分较低入院的患者中尤为明显;衰弱患者出院回家可能性更低(OR 0.36,95%CI 0.54-0.79),住院及ICU时长更长,各种器官支持使用更常见且随MFI升高而增加。

要点

  • 衰弱(MFI≥3)与院内死亡升高相关:OR 2.42(95%CI 1.89-3.08),在SOFA评分较低入院的患者中尤为明显。
  • 衰弱患者出院回家可能性更低:OR 0.36(95%CI 0.54-0.79)。
  • 衰弱患者住院及ICU时长均高于非衰弱患者。
  • 机械通气、无创通气、血管升压药、透析和输血等所有形式器官支持在衰弱患者中更常见,且随MFI升高而增加。
  • 衰弱评估(MFI)不仅关联生存,还关联ICU时长与器官支持使用等患者中心结局。

适用人群与场景

  • 2014至2015年巴西93个ICU的危重患者,共129,680例 eligible 患者纳入分析。
  • 按MFI分为非衰弱(MFI=0,40,779例,31.4%)、衰弱前期(MFI=1-2,64,407例,49.7%)和衰弱(MFI≥3,24,494例,18.9%)三组。

诊断标准与关键阈值

  • 衰弱采用改良衰弱指数(MFI)评估,定义:非衰弱 MFI=0,衰弱前期 MFI=1-2,衰弱 MFI≥3。

研究设计与关键结果

  • 研究类型:回顾性分析前瞻性收集的数据,样本量129,680例,来自巴西93个ICU,时间2014至2015年。
  • 主要结局:校正混杂后,衰弱与院内死亡升高相关(OR 2.42,95%CI 1.89-3.08),在SOFA评分较低入院的患者中尤为明显。
  • 次要结局:衰弱患者出院回家可能性更低(OR 0.36,95%CI 0.54-0.79);住院及ICU时长均高于非衰弱患者。
  • 器官支持:机械通气、无创通气、血管升压药、透析和输血等所有形式器官支持在衰弱患者中更常见,且随MFI升高而增加。

证据类型、等级与局限

  • 证据类型:回顾性分析前瞻性收集数据的观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,MFI评估的衰弱与包括生存、ICU时长及器官支持在内的多个患者中心结局相关,提示在危重患者评估中可关注衰弱状态。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Frail patients are known to experience poor outcomes. Nevertheless, we know less about how frailty manifests itself in patients' physiology during critical illness and how it affects resource use in intensive care units (ICU). We aimed to assess the association of frailty with short-term outcomes and organ support used by critically ill patients.

METHODS: Retrospective analysis of prospective collected data from 93 ICUs in Brazil from 2014 to 2015. We assessed frailty using the modified frailty index (MFI). The primary outcome was in-hospital mortality. Secondary outcomes were discharge home without need for nursing care, ICU and hospital length of stay (LOS), and utilization of ICU organ support and transfusion. We used mixed logistic regression and competing risk models accounting for relevant confounders in outcome analyses.

RESULTS: The analysis consisted of 129,680 eligible patients. There were 40,779 (31.4%) non-frail (MFI = 0), 64,407 (49.7%) pre-frail (MFI = 1-2) and 24,494 (18.9%) frail (MFI ≥ 3) patients. After adjusted analysis, frailty was associated with higher in-hospital mortality (OR 2.42, 95% CI 1.89-3.08), particularly in patients admitted with lower SOFA scores. Frail patients were less likely to be discharged home (OR 0.36, 95% CI 0.54-0.79) and had higher hospital and ICU LOS than non-frail patients. Use of all forms of organ support (mechanical ventilation, non-invasive ventilation, vasopressors, dialysis and transfusions) were more common in frail patients and increased as MFI increased.

CONCLUSIONS: Frailty, as assessed by MFI, was associated with several patient-centered endpoints including not only survival, but also ICU LOS and organ support.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Zampieri FG, Iwashyna TJ, Viglianti EM, et al. Association of frailty with short-term outcomes, organ support and resource use in critically ill patients. Intensive Care Med. 2018. PMID: 30105600. doi:10.1007/s00134-018-5342-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。